About
MFX develops the Cyto Engine, an automated bioprocessing platform and analytics suite designed to accelerate cell and gene therapy development and manufacturing, currently in prototype stage for research and development use only.
Explore MFX (microfluidx Ltd)'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.